Tammy Meyers

Summary

Publications

  1. doi request reprint Challenges to pediatric HIV care and treatment in South Africa
    Tammy Meyers
    Harriet Shezi Children s Clinic, Chris Hani Baragwanath Hospital, Johannesburg, South Africa
    J Infect Dis 196:S474-81. 2007
  2. pmc Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment
    Cordula Frohoff
    Gertrude H Sergievsky Center, College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America
    PLoS ONE 6:e17273. 2011
  3. pmc Changes in pediatric HIV-related hospital admissions and mortality in Soweto, South Africa, 1996-2011: light at the end of the tunnel?
    Tammy Meyers
    Department of Paediatrics, Harriet Shezi Clinic, Chris Hani Baragwanath Hospital, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa
    J Acquir Immune Defic Syndr 60:503-10. 2012
  4. pmc Antiretroviral therapy responses among children attending a large public clinic in Soweto, South Africa
    Tammy M Meyers
    Department of Paediatrics, Harriet Shezi Children s Clinic, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    Pediatr Infect Dis J 30:974-9. 2011
  5. doi request reprint Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial
    Ashraf Coovadia
    Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa
    JAMA 304:1082-90. 2010
  6. pmc Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis
    Cordula Reitz
    Gertrude H Sergievsky Center and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York 10032, USA
    J Infect Dis 201:1121-31. 2010
  7. doi request reprint Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial
    Louise Kuhn
    Gertrude H Sergievsky Center, College of Physicians and Surgeons, and Department of Epidemiology, Columbia University, New York, NY 10032, USA
    Lancet Infect Dis 12:521-30. 2012
  8. pmc Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy
    Kelly Smith
    Columbia University College of Physicians and Surgeons, New York, New York, USA
    AIDS 23:1097-107. 2009
  9. doi request reprint HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine
    Gillian M Hunt
    AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa
    AIDS 25:1461-9. 2011
  10. pmc Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy
    Renate Strehlau
    Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, University of the Witwatersrand, Johannesburg, South Africa
    J Acquir Immune Defic Syndr 60:369-76. 2012

Collaborators

Detail Information

Publications20

  1. doi request reprint Challenges to pediatric HIV care and treatment in South Africa
    Tammy Meyers
    Harriet Shezi Children s Clinic, Chris Hani Baragwanath Hospital, Johannesburg, South Africa
    J Infect Dis 196:S474-81. 2007
    ..This article delineates the challenges to pediatric HIV care in South Africa and provides some practical recommendations to improve it...
  2. pmc Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment
    Cordula Frohoff
    Gertrude H Sergievsky Center, College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America
    PLoS ONE 6:e17273. 2011
    ..We aimed to determine virologic and toxicity outcomes among TB/HIV co-treated children with the following modifications to their antiretroviral therapy (ART): (1) super-boosted LPV/r, (2) double-dose LPV/r or (3) ritonavir...
  3. pmc Changes in pediatric HIV-related hospital admissions and mortality in Soweto, South Africa, 1996-2011: light at the end of the tunnel?
    Tammy Meyers
    Department of Paediatrics, Harriet Shezi Clinic, Chris Hani Baragwanath Hospital, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa
    J Acquir Immune Defic Syndr 60:503-10. 2012
    ....
  4. pmc Antiretroviral therapy responses among children attending a large public clinic in Soweto, South Africa
    Tammy M Meyers
    Department of Paediatrics, Harriet Shezi Children s Clinic, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    Pediatr Infect Dis J 30:974-9. 2011
    ..The aim of this study was to determine treatment responses of children in a routine setting where first-line therapy with lopinavir/ritonavir is routinely included for young children...
  5. doi request reprint Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial
    Ashraf Coovadia
    Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa
    JAMA 304:1082-90. 2010
    ..However, there are limitations of continuing PI-based therapy indefinitely and reuse of nevirapine has many advantages...
  6. pmc Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis
    Cordula Reitz
    Gertrude H Sergievsky Center and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York 10032, USA
    J Infect Dis 201:1121-31. 2010
    ..We investigated factors associated with viral suppression and mortality among young children initiating ART...
  7. doi request reprint Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial
    Louise Kuhn
    Gertrude H Sergievsky Center, College of Physicians and Surgeons, and Department of Epidemiology, Columbia University, New York, NY 10032, USA
    Lancet Infect Dis 12:521-30. 2012
    ..We present the long-term outcomes of switching nevirapine-exposed children to nevirapine-based treatment after effective suppression of virus replication with a protease-inhibitor-based regimen...
  8. pmc Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy
    Kelly Smith
    Columbia University College of Physicians and Surgeons, New York, New York, USA
    AIDS 23:1097-107. 2009
    ..To determine the incidence, clinical manifestations and risk factors for immune reconstitution inflammatory syndrome (IRIS) in young children initiating highly active antiretroviral therapy (HAART)...
  9. doi request reprint HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine
    Gillian M Hunt
    AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa
    AIDS 25:1461-9. 2011
    ..To describe the prevalence of HIV-1 drug resistance mutations at the time of treatment initiation in a large cohort of HIV-infected children previously exposed to single-dose nevirapine (sdNVP) for prevention of transmission...
  10. pmc Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy
    Renate Strehlau
    Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, University of the Witwatersrand, Johannesburg, South Africa
    J Acquir Immune Defic Syndr 60:369-76. 2012
    ..Here we examined lipid profile changes in a cohort of young children before and after suppression on an initial ritonavir-boosted lopinavir (LPV/r)-based regimen and after switch to a nevirapine (NVP)-based regimen...
  11. doi request reprint Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa
    Megan Palmer
    Department of Paediatrics, Chris Hani Baragwanath Hospital, Johannesburg, South Africa
    AIDS 27:781-5. 2013
    ..We describe the frequency of stavudine toxicity in children receiving ART at a treatment clinic in Soweto, South Africa...
  12. pmc Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy
    Ashraf Coovadia
    Empilweni Clinic, Coronation Women and Children Hospital, Johannesburg, South Africa
    Clin Infect Dis 48:462-72. 2009
    ....
  13. pmc 4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response
    Elin S Gray
    National Institute for Communicable Diseases, Johannesburg, Private Bag X4, Sandringham 2131, Johannesburg, South Africa
    J Virol 82:2367-75. 2008
    ..Collectively, these genetic changes in the face of a neutralizing antibody response to the MPER strongly suggested immune escape from antibody responses targeting this region...
  14. ncbi request reprint Surgeons are failing to recognize children with HIV infection
    Douglas M Bowley
    Division of Paediatric Surgery, University of the Witwatersrand, Johannesburg 2000, South Africa
    J Pediatr Surg 42:431-4. 2007
    ....
  15. pmc Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B
    Elin Solomonovna Gray
    AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa
    PLoS Med 3:e255. 2006
    ..To assess the suitability of such an approach, we determined the sensitivity of paediatric HIV-1 subtype C viruses to the broadly neutralising MAbs IgG1b12, 2G12, 2F5, and 4E10...
  16. ncbi request reprint Effect of baseline immune suppression on growth recovery in HIV positive South African children receiving antiretroviral treatment
    Lydia Feinstein
    Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    J Acquir Immune Defic Syndr 61:235-42. 2012
    ..Growth failure is common among children infected with HIV. The degree of growth recovery and its determinants in children initiating combination antiretroviral therapy (cART) are not well understood...
  17. doi request reprint Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa
    Sarah Lowick
    WITS Reproductive Health and HIV Institute, Faculty of Health Sciences, University of Witwatersrand, Johannesburg
    Psychol Health Med 17:599-610. 2012
    ..Early initiation of ART in HIV-infected infants may improve cognitive functioning among this group; however, intervention strategies which optimize early cognitive development for all children in the area need to be urgently considered...
  18. ncbi request reprint Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression
    Isaac Choge
    AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa
    AIDS Res Hum Retroviruses 22:458-65. 2006
    ..Similar to adults, CXCR4 usage was uncommon among HIV-1 subtype C isolates from pediatric infections...
  19. ncbi request reprint Polymorphisms in Nef associated with different clinical outcomes in HIV type 1 subtype C-infected children
    Polly R Walker
    Department of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK
    AIDS Res Hum Retroviruses 23:204-15. 2007
    ..These data broadly reflect previous studies on subtype B, corroborate the decreased cytopathicity of SP viruses, but also highlight potential subtype differences that require further investigation...
  20. ncbi request reprint Barriers to disclosure to children with HIV
    Fiona G Kouyoumdjian
    Dalhousie University Medical School, Halifax, Nova Scotia, Canada
    J Trop Pediatr 51:285-7. 2005
    ..Health care and social service providers could facilitate disclosure of illness to children with HIV...